Source: Life Care News

Tempus: Tempus Exhibits 4 Abstracts at the 2025 American College of Cardiology Annual Meeting

CHICAGO-(BUSINESS WIRE)-Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the company is scheduled to exhibit 4 abstracts at the American College of Cardiology (ACC) Annual Meeting, which convenes from March 29-31 in Chicago, Illinois. This is the first year that Tempus [...]

Read full article »
Annual Revenue
$500M-1.0B
Employees
1.0-5.0K
Eric Lefkofsky's photo - Founder & CEO of Tempus

Founder & CEO

Eric Lefkofsky

CEO Approval Rating

100/100

Read more